Applications for the ECTS Academy are now open! Are you, or someone you know, a dedicated early-career researcher or clinician in the musculoskeletal field? This is your chance to join a community of future leaders. Deadline: 16 Nov 2025. Basic: buff.ly/DAWdYai; Clinical: buff.ly/O7VmKlY

Morten 🇩🇰, a young MD PhD, navigates the crossroads of cellular science 🧑‍🔬 and patient care 👨‍⚕️, intrigued by #Sclerostin and how weight loss affects #Musculoskeletal balance. When time permits, he indulges in football and beers. Any Liverpool supporters here? #FootballFan

- Ectsoc Ectsoc

#ECTS2026 Abstract Submission is open! Share your Abstracts or Clinical Cases at the ECTS Annual Meeting from 5 September to 8 December 2025. A panel will review submissions based on scientific/clinical merit for oral or poster presentations. Check our site for Abstract guidelines:

Federica will be part of our team in 2025! As a Principal Investigator in Pisa 🇮🇹, she excels in using Mass Spectrometry for translational research, aiming to discover new biomarkers and treatments for musculoskeletal disorders. Another pizza enthusiast 🍕 in our crew! #MassSpectrometry #Biomarkers

The moment has arrived to welcome the newest members of our Academy. To begin, we introduce Nikola Stokovic from Croatia 🇭🇷 . Nikola is passionate about crafting applications for bone 🦴 regeneration using #BMPs, all while savoring a delightful Mediterranean pizza 🍕 ! Be sure you check his ID card 👀!

Interested in joining the @ectssociety.bsky.social #Academy? Inspired by Young Academies, this allows emerging researchers to build their networks and connect with top scientists in #MSK studies across Europe. Hear from our co-chair @jakobstaruplinde.bsky.social: vimeo.com/user6900705/... #PhD

Stay updated with clinical breakthroughs at your pace! Our adaptable, evidence-based online course lets you enhance your skills from your practice. 🌟

🔹 Learn from top experts
🔹 Earn 10-12 EACCME credits
🔹 Implement practical strategies now

#ClinicalEducation #BoneHealth

buff.ly/ICa3ke6

#ECTS2026 Abstract Submission is open! Have research or a case to present to your medical and scientific colleagues at the #ECTS2026 meeting? Submit your work from 5 Sep to 8 Dec 2025. Acceptance notifications come via email in the week of 2 Feb 2026.
buff.ly/8lNwngd

Individual Membership - Ectsoc Ectsoc

Renew your 2026 ECTS #membership today! Unlock career-boosting opportunities: educational resources, #grants, and #networking in the musculoskeletal field. Enjoy event discounts and cutting-edge webcasts. Special rates for students and more. Join now!

... Just following our famous #Academy members retreat! Apply to become an @ectssociety.bsky.social Young Academy member and enjoy benefits like this one! #Earlycareer #YoungPI #PhD

Secure your spot for the famous ECTS PhD training course!

buff.ly/zUTBQ6h

We are delighted to invite you to the 53rd European Calcified Tissue Society (ECTS) annual congress taking place 24-27 April 2026 in Girona, Spain!

Save the date: 24-27 April 2026 - an inspiring event awaits!

buff.ly/DBkfLrV

Early-Onset Osteoporosis: Genetics, Filtering, and Functional... by Faculty / Presenters ECTS eCampus; Presenters F. Oct 16 2025; 4188323;

Join our RARE BONE 🦴 DISEASE webinar on Thursday, 16 Oct, 16:00-17:00 CET! Explore "Early-Onset Osteoporosis: Genetics, Filtering, and Functional Modelling" with experts Pr Dr Melissa Formosa & Pr Dr Ralf Oheim. Secure your spot now: buff.ly/m06dHJq #RareDiseases #Osteoporosis

🎒 Back-to-school season is here – and so is the reminder that healthy bones start early

At ECTS, we believe that investing in bone health in young people means investing in healthier futures.

✅ Encourage daily movement
✅ Support calcium+vitamin D intake
✅ Raise awareness of bone health in schools

Even if you're on a short holiday 🏖️ break, this is something you won't want to miss!

Our condolences Michaël! 😅

🌞 Back from holidays? Time to swap suitcases for science!✨ WEBINAR COMING SOON 💡📅 Thursday, 21 August | 4:00–5:00 PM CET
Hyperphosphatemic Familial Tumoral Calcinosis is a rare subtype of hereditary familial tumoral calcinosis, where high blood phosphate drives calcium deposits around joints.

Did you know there’s a rare bone disorder that even experts find challenging?

✨ Join our Free webinar on rare bone disease Hereditary Familial Tumoral Calcinosis (HFTC)
🗓 Aug 21, 4–5 PM CET
🎤 Dr. Kelly Roszko & Prof. Natasha Appelman-Dijkstra
🎟 Register now 👉 ecampus.ectsoc.org/ects/2025/he...

Dario’s and Valentina’s families visited our lab yesterday! 💙 Thanks to their parents’ tireless efforts, we will start a joint project with the University of Barcelona to explore new therapeutic options for the #raredisease #FOP. #BMP #ISPA @rarascsic.bsky.social @csic.es www.lne.es/asturias/202...

Cathepsin K inhibitors promote osteoclast-osteoblast communication and engagement of osteogenesis Abstract. Cathepsin K inhibitors are well known for their inhibitory activity against bone resorption but were also reported to preserve bone formation in

New paper out in JBMRPlus !
Using a time-lapse co-culture approach with #osteoclasts and reversal cells, we show that reversal cells prefer pits over trenches, but that intermediate #CatK inhibition boosts their attraction and maturation into #osteoblasts.
track.smtpsendmail.com/9032119/c?p=...

Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the ECTS. AM Naciu et al. Bone 26 July 2025 shorturl.at/pyzoe

Call for Open Fora and Workshop Suggestions for ECTS 2026 Congress in Girona

Open Fora offer a fantastic opportunity to inform the ECTS community on topics that are significant to you, achieve global recognition, and expand your influence by participating in the ECTS Annual Congress
buff.ly/56T9C71

GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial - Nature Communications GDF8 and activin A are the dominant negative regulators of muscle mass in animal models. This two-part, randomized, placebo-controlled Phase 1 trial suggests that GDF8 and activin A are also the domin...

GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial
www.nature.com/articles/s41...

The ECTS 2025 conference may be over, but ECTS 2026 is already on the horizon! Save the date for #ECTS2026 in Girona, Spain, 24-27 April

And we have a winner of our first #ECTSAcademy2025 Photo Competition!!! Vivi Mäkinen receives the award from Charlotte Verroken. 🎉🥳 #ECTS2025

Jelena Jadzic is the recipient of the Poster Forum Basic Award! Congratulations! The award is presented by Christina Andreasen and Felix von Brackel #ECTS2025

Congratulations Elizabeth Orhadje to win the Clinical Poster Forum!!! Academy members @jakobstaruplinde.bsky.social and Charlotte Verroken handing in the award #ECTS2025

Don't forget to drop by the #Academy Lounge to know the winner of the #ECTS2025 🇦🇹 Photo 📷 Competition!!! #ECTSAcademy2025

If you're not here yet, quickly move to Room Freiburg to visit the Poster "Deciphering early-onset hip osteoarthritis in COL2A1-related spondyloepiphyseal dysplasia and its corresponding mouse model" by the group of Dr. Tim Rolvien 🇩🇪. #ECTS2025